Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) for patients with Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR1) is much more intensive than multi-agent combined chemotherapy, although allogeneic HSCT is associated wit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nagafuji, Koji, Miyamoto, Toshihiro, Eto, Tetsuya, Kamimura, Tomohiko, Taniguchi, Shuichi, Okamura, Takashi, Ohtsuka, Eiichi, Yoshida, Takashi, Higuchi, Masakazu, Yoshimoto, Goichi, Fujisaki, Tomoaki, Abe, Yasunobu, Takamatsu, Yasushi, Yokota, Shouhei, Akashi, Koichi, Harada, Mine
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3574830/
https://ncbi.nlm.nih.gov/pubmed/23388549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi